Li Wen-Juan, Nie Shao-Ping, Yao Yu-Fei, Liu Xiao-Zhen, Shao Deng-Yin, Gong De-Ming, Cui Steve W, Phillips Glyn O, He Ming, Xie Ming-Yong
State Key Laboratory of Food Science and Technology, Nanchang University , 235 Nanjing East Road, Nanchang 330047, China.
China People's Liberation Army No. 94 Hospital, No. 1028, Jinggangshan Avenue, Nanchang 330000, China.
J Agric Food Chem. 2015 Sep 23;63(37):8182-91. doi: 10.1021/acs.jafc.5b03462. Epub 2015 Sep 8.
The aim of the present study was to examine the role of Ganoderma atrum polysaccharide (PSG-1) in reactive oxygen species (ROS) generation and mitochondrial function in hyperglycemia-induced angiopathy. In this work, ROS scavenger, oxidizing agent tert-butylhydroperoxide (tBH), mitochondrial permeability transition pore (mPTP) blockers, and caspase inhibition are used to investigate whether PSG-1 may promote survival of human umbilical vein cells (HUVECs) through preventing the overproduction of ROS and mitochondrial dysfunction. Experimental results show that exposure of HUVECs to 35.5 mmol/L glucose increases the proportion of cells undergoing apoptosis. PSG-1, mPTP blocker, or caspase inhibition can reduce apoptosis and ROS generation. PSG-1 also increases mitochondrial Bcl-2 protein formation and mitochondrial membrane potential (ΔΨm) but inhibits Bax translocation, cytochrome c release, and caspase activation. In summary, vascular protection of PSG-1 can be mediated by a mitochondria-ROS pathway. ROS generation and mPTP induction are critical for high glucose-mediated apoptosis. PSG-1 ameliorates endothelial dysfunction by inhibiting oxidative stress and subsequent mitochondrial dysfunction.
本研究的目的是探讨黑灵芝多糖(PSG-1)在高血糖诱导的血管病变中活性氧(ROS)生成及线粒体功能方面的作用。在本研究中,使用ROS清除剂、氧化剂叔丁基过氧化氢(tBH)、线粒体通透性转换孔(mPTP)阻滞剂和半胱天冬酶抑制剂,来研究PSG-1是否可通过防止ROS过量生成和线粒体功能障碍来促进人脐静脉内皮细胞(HUVECs)的存活。实验结果表明,将HUVECs暴露于35.5 mmol/L葡萄糖会增加细胞凋亡比例。PSG-1、mPTP阻滞剂或半胱天冬酶抑制均可减少细胞凋亡和ROS生成。PSG-1还可增加线粒体Bcl-2蛋白的形成及线粒体膜电位(ΔΨm),但抑制Bax易位、细胞色素c释放和半胱天冬酶激活。总之,PSG-1的血管保护作用可通过线粒体-ROS途径介导。ROS生成和mPTP诱导对高糖介导的细胞凋亡至关重要。PSG-1通过抑制氧化应激及随后的线粒体功能障碍来改善内皮功能障碍。